Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments ...

This update from UHC includes procedures enabled with its OMNI Surgical System technology from Sight Sciences.

The OMNI Surgical System (OMNI) is FDA-cleared and indicated for canaloplasty followed by trabeculotomy to reduce intraocular pressure (IOP) in adult patients with primary open angle glaucoma. The ...

RANTUOL, Ill. (WCIA) — There are new treatments to help patients with glaucoma, and they’re just in time. The disease is the second leading cause of blindness worldwide. It’s a condition that damages ...

Glaucoma is one of the most common causes of irreversible vision loss, especially in older adults. It slowly damages the ...

DelveInsight's Open-Angle Glaucoma Market Insights report includes a comprehensive understanding of current treatment practices, emerging open-angle glaucoma drugs, market share of individual ...

Glaukos' glaucoma treatment is set to address chronic side effects associated with skin medications by providing long-duration therapy. Dallas-based Celanese Corporation (NYSE: CE) partners with ...

Researchers discovered that glaucoma patients have less of two tiny molecules in the clear fluid at the front of the eye, compared to those without glaucoma. These two metabolites, agmatine and ...

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...

Glaucoma, a leading cause of preventable blindness in the UK, often progresses silently, damaging the optic nerve and causing irreversible vision loss ...

The Cleveland Clinic explains that glaucoma, also referred to as the “silent thief of sight,” is a group of eye diseases that gradually damage the optic nerve, typically due to increased pressure ...